Compounds > ethyl pyruvate
Page last updated: 2024-08-21

ethyl pyruvate and Liver Failure, Acute

ethyl pyruvate has been researched along with Liver Failure, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, ZJ; Han, XQ; Li, X; Wang, LK; Wang, LW1
Chen, H; Fan, C; Gong, ZJ; He, CM; Li, X; Wang, LK; Wang, LW1

Other Studies

2 other study(ies) available for ethyl pyruvate and Liver Failure, Acute

ArticleYear
Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2013, Volume: 12, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Bacterial Translocation; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Endotoxins; Galactosamine; Inflammation Mediators; Intestinal Mucosa; Liver; Liver Failure, Acute; Male; Permeability; Pyruvates; Rats; Rats, Wistar; Time Factors

2013
Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats.
    World journal of gastroenterology, 2012, Oct-28, Volume: 18, Issue:40

    Topics: Animals; Biomarkers; Cytokines; Cytoprotection; Disease Models, Animal; End Stage Liver Disease; Endotoxins; Female; HMGB1 Protein; Inflammation Mediators; Liver; Liver Failure, Acute; Protective Agents; Pyruvates; Rats; Rats, Wistar; Severity of Illness Index; Time Factors

2012